Validation of a Simplified Severity Score (Investigator Global Assessment: IGA) in Bullous Pemphigoid
NCT05366127 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2022-05-09
Summary
The aim of the study is to validate a global and simple score : IGA (Investigator Global Assessment) score for the evaluation of the extent and severity of the disease in patients with bullous pemphigoid
Conditions
- Bullous Pemphigoid
Interventions
- OTHER
-
IGA score
IGA score will be assessed by 2 blinded investigators
- OTHER
-
BULLOUS PEMPHIGOID DISEASE AREA INDEX (BPDAI)
BPDAI will be assessed by 2 by 2 blinded investigators
Sponsors & Collaborators
-
University Hospital, Rouen
lead OTHER
Principal Investigators
-
Pascal JOLY · University Hospital, Rouen
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-07-01
- Primary Completion
- 2026-07-30
- Completion
- 2026-07-30
Countries
- France
Study Locations
More Related Trials
-
Pharmacokinetics Study of Mycophenolic Acid in Patients With an Autoimmune Bullous Dermatose, Pemphigus or Cicatricial Pemphigoid.
NCT02993133 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Glucocorticoids Plus Rituximab in Patients with Newly-Diagnosed or Relapsing IgA Vasculitis
NCT05329090 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Cytokines in Blister Fluids of Bullous Pemphigoid (BP)
NCT03856840 ·Status: COMPLETED
-
A Prospective & Retrospective Study on Ectopic Lymphoid-like Structures in Chronic Skins of Autoimmune Bullous Diseases
NCT04509570 ·Status: COMPLETED ·Phase: NA
-
Identification of Biomarkers Predictive of Worse Prognosis in Henoch Schonlein Purpura
NCT01610830 ·Status: UNKNOWN
-
Phase III Clinical Trial of NPB-01 in Patients With Bullous Pemphigoid Unresponsive to Corticosteroids
NCT01408550 ·Status: COMPLETED ·Phase: PHASE3
-
Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.
NCT04662723 ·Status: RECRUITING ·Phase: PHASE4
-
Role of Femoral Vein Wall Thickness and Inflammatory Markers in Patients With Behcet Disease
NCT06721234 ·Status: RECRUITING
-
Comparison Between Rituximab Treatment and General Corticotherapy Treatment in Patients With Pemphigus
NCT00784589 ·Status: COMPLETED ·Phase: PHASE3
-
INS, B Cells and Microbiota
NCT04924712 ·Status: RECRUITING
-
Study of Subcutaneous Injection of Low-dose rhGM-CSF +/- WLL in PAP.
NCT01983657 ·Status: UNKNOWN ·Phase: PHASE2
-
An Open-Label, Nonrandomized, Multicenter Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan in Participants With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis
NCT05809531 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
European Trial of Adjuvant Oral Glucocorticoid Pulse Therapy in Pemphigus
NCT00127764 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Phase II Study on Gusperimus in Patients With Refractory Wegener's Granulomatosis
NCT00530075 ·Status: COMPLETED ·Phase: PHASE2
-
Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis
NCT00315393 ·Status: COMPLETED
-
MPA AUC Monitoring in Patients Receiving MMF for Diffuse Cutaneous or Pulmonary Involvement in Systemic Sclerosis
NCT04244916 ·Status: TERMINATED
-
Inhibitors of Angiotensin II in Proteinuric Mesangioproliferative Glomerulonephritis
NCT01115426 ·Status: COMPLETED ·Phase: PHASE4
-
From Immune System Damage to Podocyte Cell Damage: Prospective Database and Biological Collection of Patients (Children and Adults) With MGLS and HSFP
NCT04174066 ·Status: UNKNOWN
-
Rapid Diagnostic Test for Septic Arthritis
NCT04460144 ·Status: COMPLETED
-
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
NCT05755386 ·Status: RECRUITING ·Phase: PHASE3
-
Phenotypic Expressions in a French Pseudoxanthoma-Elasticum Cohort
NCT01446380 ·Status: UNKNOWN
-
Prognostic Analyses on a Validation Series of Patients With Waldenström's Disease
NCT05911802 ·Status: RECRUITING
-
Intravenous Immunoglobulin After Relapse in Vasculitis
NCT00307658 ·Status: TERMINATED ·Phase: PHASE3
-
Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile Dermatomyositis
NCT00059748 ·Status: RECRUITING
-
Rituximab Plus Corticosteroids in Non-infectious Active Mixed Cryoglobulinemia Vasculitis
NCT02556866 ·Status: TERMINATED ·Phase: PHASE2